A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ivonescimab
Related studies linked through entity extraction aliases.
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in People With Leiomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ctDNA-guided Treatment Decision-making
- Status
- RECRUITING
- Phase
- PHASE2
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in First-Line ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
A Randomized Phase II Study Evaluating Upfront SRT to All Brain Metastases Followed by Ivonescimab Plus Chemotherapy Versus Upfront Ivonescimab Plus Chemotherapy in Patients With Asymptomatic Active Brain Metastases From NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2